Science, Startups, and Serendipity: Full "raw" session with Devon Cayer

Steve sits down with scientist and entrepreneur Devon Cayer for a full, unedited "raw" session on the messy, serendipitous path from chemistry bench to biotech founder.

Devon traces his journey from UCLA chemistry and the Stoddart Group, through a pivot into molecular biology via iGEM, into entrepreneurship aimed at making drug-discovery data accessible to everyone. The conversation is candid about failure: a memorable lab accident, an earlier startup that didn't work, and the lessons those taught about holding conviction in your vision under investor pressure. Devon's current work focuses on generating proteome-wide binding datasets for the broader scientific community rather than chasing traditional venture-backed therapeutics.

Topics: organic synthesis, drug discovery and proteomics, academia to entrepreneurship, learning from failure and pivoting, founder vision vs. investor expectations, and democratizing scientific data.

Read the companion piece on Renaissance Circle / Substack:
https://www.drstevenmuskal.com/p/science-startups-and-serendipity

About Steven Muskal, Ph.D.
AI pioneer, drug discovery expert, drummer, and host of the Renaissance Circle podcast. CEO of Eidogen-Sertanty. More at https://www.stevenmuskal.com

More links
Website: https://www.stevenmuskal.com
Renaissance Circle podcast: https://www.drstevenmuskal.com
Substack: https://stevenmuskal.substack.com
LinkedIn: https://www.linkedin.com/in/stevenmuskal/

#RenaissanceCircle #DevonCayer #DrugDiscovery #Proteomics #Chemistry #Biotech #Startups #Entrepreneurship #ScienceStartups #StevenMuskal #DrStevenMuskal #Substack #Podcast #RenaissanceCirclePodcast

Видео Science, Startups, and Serendipity: Full "raw" session with Devon Cayer канала Renaissance Circle